Cargando…
Humanized c-Myc Mouse
BACKGROUND: A given tumor is usually dependent on the oncogene that is activated in the respective tumor entity. This phenomenon called oncogene addiction provides the rationale for attempts to target oncogene products in a therapeutic manner, be it by small molecules, by small interfering RNAs (siR...
Autores principales: | Lehmann, Frank M., Feicht, Samantha, Helm, Florian, Maurberger, Anna, Ladinig, Camilla, Zimber-Strobl, Ursula, Kühn, Ralf, Mautner, Josef, Gerbitz, Armin, Bornkamm, Georg W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409231/ https://www.ncbi.nlm.nih.gov/pubmed/22860051 http://dx.doi.org/10.1371/journal.pone.0042021 |
Ejemplares similares
-
Targeting c-MYC with T-Cells
por: Helm, Florian, et al.
Publicado: (2013) -
Stromal Interferon-γ Signaling and Cross-Presentation Are Required to Eliminate Antigen-Loss Variants of B Cell Lymphomas in Mice
por: Gerbitz, Armin, et al.
Publicado: (2012) -
Virus and Autoantigen-Specific CD4+ T Cells Are Key Effectors in a SCID Mouse Model of EBV-Associated Post-Transplant Lymphoproliferative Disorders
por: Linnerbauer, Stefanie, et al.
Publicado: (2014) -
c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells
por: David, Amandine, et al.
Publicado: (2017) -
An RNAi-Based Approach to Down-Regulate a Gene Family In Vivo
por: Kim, Jeehee, et al.
Publicado: (2013)